Apellis Pharmaceuticals, Inc. — Director's Dealing 2018

May 9, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Apellis Pharmaceuticals, Inc. (APLS)
CIK: 0001492422
Period of Report: 2018-05-07

Reporting Person: Deschatelets Pascal (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-07	Common Stock	J	384292	$0.00	Acquired	945744	Direct

Footnotes

F1: Distribution from Potentia Holdings, LLC, of which the reporting person is the chief operating officer.